Eagle Health Investments’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Eagle Health Investments's GH Position: Q2 2026 in Review
Eagle Health Investments reduced its Guardant Health (GH) stake by 3.1% in Q2 2026, selling an estimated $1.04M and leaving 300,685 shares worth $45.1M. The position accounts for 7.48% of the portfolio, ranked #3.
Eagle Health Investments first reported a position in GH in Q4 2020 and has held it in 20 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Eagle Health Investments held 300,685 shares of Guardant Health worth $45.1M as of Q2 2026.
- Eagle Health Investments sold 9,596 Guardant Health shares in Q2 2026, an estimated $1.04M.
- Guardant Health made up 7.48% of Eagle Health Investments's portfolio in Q2 2026, its #3 holding.
- Eagle Health Investments first reported a position in Guardant Health in Q4 2020 and has held it in 20 quarters since.
- 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.